View More Recent Stories
-
AtriCure (ATRC) Reports In-Line Q2 EPS, provides guidance
-
AtriCure (ATRC) Receives Regulatory Approval to Sell AtriClip Devices in China
-
AtriCure Inc. (ATRC) PT Lowered to $35 at UBS
-
AtriCure (ATRC) July 20, 25 and 35 calls active
-
AtriCure (ATRC) July 20, 25 and 35 calls active
-
Edwards Lifesciences (EW) said to mull takeover bid for AtriCure (ATRC) - source

